This Article  • Full text  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (8)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Lipids and Lipid Disorders  • Cardiovascular System  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic  Social Bookmarking   What's this?

Arch Intern Med. 1998;158:1395-1396.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

TRADITIONAL RISK factors such as cigarette smoking, hypertension, dyslipidemia, diabetes mellitus, sedentary lifestyle, obesity, imbalance of the hemostatic/fibrinolytic system, and family history of premature coronary disease play an important role in the development and progression of atherosclerosis and in the predisposition for unstable angina, myocardial infarction, and stroke.^1-2 It is also increasingly clear that modification of these risk factors, in particular smoking cessation, control of hypertension, and vigorous treatment of hyperlipidemia, can favorably alter the natural progression of coronary heart disease and cerebrovascular disease.³ At the same time, clinicians are often confronted with patients who suffer cardiovascular events in the apparent absence of predisposing factors. Furthermore, in even the most successful clinical trials, less than 50% of cardiovascular events are prevented in treatment groups. Thus, much of the variability of atherosclerosis and its manifestations remains unexplained.

There is increasing evidence that inflammation and immunologic mechanisms play a major role in . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Prediction of Myocardial Infarction in Dyslipidemic Men by Elevated Levels of Immunoglobulin Classes A, E, and G, but Not M
Petri T. Kovanen, Matti Mänttäri, Timo Palosuo, Vesa Manninen, and Kimmo Aho
Arch Intern Med. 1998;158(13):1434-1439.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Poor Outcomes After Acute Myocardial Infarction in Systemic Lupus Erythematosus
SHAH et al.
The Journal of Rheumatology 2009;36:570-575.
ABSTRACT | FULL TEXT  

Systemic lupus erythematosus: a model for atherogenesis?
Manzi
Rheumatology (Oxford) 2000;39:353-359.
FULL TEXT  

Atherosclerosis and the Immune System
Niculescu and Rus
Arch Intern Med 1999;159:315-315.
FULL TEXT